Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary syndrome

Ultrasound in Obstetrics and Gynecology

Volumn 12, Issue 3, 1998, Pages 180-187

  Battaglia, C ^a   Genazzani, A D ^a   Artini, P G ^b   Salvatori, M ^a   Giulini, S ^a   Volpe, A ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b NONE

Author keywords

Doppler; GnRH A; Hirsutism; PCOS; Therapy; Ultrasonography

Indexed keywords

ANDROSTENEDIONE; DESOGESTREL PLUS ETHINYLESTRADIOL; ESTRADIOL; FOLLITROPIN; GONADORELIN; LEUPRORELIN; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; OVARY POLYCYSTIC DISEASE; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ULTRASOUND; VASCULARIZATION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CONTRACEPTIVES, ORAL; DELAYED-ACTION PREPARATIONS; DRUG THERAPY, COMBINATION; FEMALE; FOLLICLE STIMULATING HORMONE; FOLLOW-UP STUDIES; HUMANS; LEUPROLIDE; LINEAR MODELS; LUTEINIZING HORMONE; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; ULTRASONOGRAPHY; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0031663946     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0705.1998.12030180.x     Document Type: Article

References (30)

1. Homburg R. Polycystic ovary syndrome from gynaecological curiosity to multisystem endocrinopathy. Hum Reprod 1996; 11:29-39
2. Koskinen P, Penttila TA, Anttiln L, Erkkola R, Irjala K. Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome. Fertil Steril 1996;65: 517-22
3. Couzinet B, Strat NL, Brailly S, Schaison G. Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease. J Clin Endocrinol Metab 1986;63:1031-5
4. Falsetti L, Galbignani E. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome. Contraception 1990;42:61 1-19
5. Morcos RN, Abdul-Malk ME, Shikora E. Treatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy. Fertil Steril 1994;61:427-31
6. Elkind-Hirsch KE, Anania C, Mack M, Malinak R. Combination gonadotropin-releasing hormone agonist and oral contraceptive therapy improves treatment of hirsute women with ovarian hyperandrogenism. Fertil Steril 1996;63:970-8
7. Rittmaster RS, Arab DM, Lehman L. Dose-response effect of depot leuprolide acetate on serum androgens in hirsute women. Fertil Steril 1996;65:912-15
8. Battaglia C, Volpe A. Leuprolin: pharmacodynamics in the female. Horm Ther Obstet Gynecol 1996;1:17-22
9. Carr BR, Breslau NA, Givens C, Byrd W, Barnett-Hamm C, Marshburn PB. Oral contraceptive pills, gonadotropin-releasing hormone agonist, or use in combination for treatment of hirsutism: a clinical research center study. J Clin Endocrinol Metab 1995;80:1169-78
10. Ciotta I., Cianci A, Giuffrida G, Marletta E, Aglianó A, Palumbo G. Clinical and hormonal effects of gonadotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary disease. Fertil Steril 1996;65:61-7
11. Battaglia C, Artini PG, D'Ambrogio G, Genazzani AD, Genazzani AR. The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome. Am J Obstet Gynecol 1995;172:108-13
12. Battaglia C, Artini PG, Genazzani AD, Sgherzi MR, Salvatori M, Giulini S, Volpe A. Color Doppler analysis in lean and obese women with polycystic ovary syndrome. Ultrasound Obstet Gynecol 1996;7:342-6
13. Battaglia C, Artini PG, Genazzani AD, Florio P, Salvatori M, Sgherzi MR, Giulini S, Lombardo M, Volpe A. Color Doppler analysis in oligo and amenorrheic women with polycystic ovary syndrome. Gynecol Endocrinol 1997;11:105-10
14. Takahashi K, Eda Y, Abu-Musa A, Okada S, Yoshino K, Kitao M. Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovary syndrome. Hum Reprod 1994;9:1231-9
15. Ferriman D, Gallwey GD. Clinical assessment of body hair growth in women. J Clin Endocrinol 1971;21:1440-7
16. Genazzani AD, Petraglia F, Battaglia C, Gamba O, Volpe A, Genazzani AR. A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. Fertil Steril 1997;67:463-8
17. Pache TD, De Jong FH, Hop WC, Fauser BCJM. Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome. Fertil Steril 1993;59:544-9
18. Zaidi J, Jurkovic D, Campbell S, Okokon E, Tan SL. Circadian variation in uterine artery blood flow indices during the follicular phase of the menstrual cycle. Ultrasound Obstet Gynecol 1995;5:406-10
19. Battaglia C, Artini PG, D'Ambrogio G, Galli PA, Genazzani AR. Uterine and ovarian blood flow measurements. Does the full bladder modify the flow resistance? Acta Obstet Gynecol Scand 1994;73:716-18
20. Ruchhoft EA, Elkind-Hirsch KE, Malinak R. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist. Fertil Steril 1996;66:54-60
21. Pang S. Relevance of biological properties of progestogen of oral contraceptive in the treatment of androgen excess symptoms. J Clin Endocrinol Metab 1990;71:5-7
22. Adashi EY. Potential utility of gonadotropin-releasing hormone agonists in the management of ovarian hyperandrogenism. Fertil Steril 1990;53:765-9
23. Hemrika DW, Slaats EH, Kennedy JC, Ted JM. Pulsatile luteinizing hormone patterns in long-term oral contraceptive users. J Clin Endocrinol Metab 1993;77:420-8
24. Tiitinnen A, Simberg N, Stenman U, Ylikorkala O. Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism. J Clin Endocrinol Metab 1994;79:447-51
25. Reissman TH, Felderbaum R, Diedrich K, Engel J, ComaruSchally AM, Schally A. Development and applications of luteinizing hormone releasing hormone antagonists in the treatment of infertility: an overview. Hum Reprod 1995;10: 1974-8
26. Goswamy RK, Williams G, Steptoe PC. Decreased uterine perfusion - a cause of infertility. Hum Reprod 1988;3:955-9
27. Battaglia C, Larocca E, Lanzani A, Valentini M, Genazzani AR. Doppler ultrasound studies of the uterine arteries in spontaneous and IVF stimulated ovarian cycle. Gynecol Endocrinol 1990;4:245-50
28. Taskin O, Yalcinoglu AI, Kafkasli A, Burak F, Ozekici U. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease. Fertil Steril 1996;65:1115-18
29. Dabirashrafi H, Mohamad K, Behjatnia Y, MoghadamiTabrizi N. Adhesion formation after ovarian electrocauterization on patients with polycystic ovary syndrome. Fertil Steril 1991;55:1200-1
30. Falsetti I, Pasinetti E, Chiode C, Grigolato PG. Treatment of moderate and severe hirsutism with a gonadotropin-releasing hormone agonist. Hum Reprod 1992;6:894-8